68-Ga SNA 017
Alternative Names: 68-Ga SNA 017 - SmartNuclide Biopharma; 68-Ga SNA-017Latest Information Update: 18 Jan 2024
At a glance
- Originator SmartNuclide Biopharma
- Class Antineoplastics; Diagnostic agents; Imaging agents; Radioisotopes; Radiopharmaceutical diagnostics
- Mechanism of Action Diagnostic imaging enhancers; Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Solid tumours
Most Recent Events
- 22 Aug 2023 Preclinical trials in Solid tumours (Diagnosis) in China (unspecified route) (SmartNuclide pipeline, August 2023)